期刊文献+

大肠癌干细胞基因Bmi-1的表达及临床病理意义 被引量:6

The correlation between genetic expressions of Bmi-1 and clinicopathological parameters of colorectal cancer
下载PDF
导出
摘要 目的探讨大肠癌干细胞基因Bmi-1在蛋白和RNA的表达水平及其与临床病理的关系。方法采用SYBR Green实时定量RT-PCR技术检测35例大肠癌组织及相应癌旁和远端正常组织中Bmi-1 mRNA的表达;常规HE染色和免疫组化SP法检测肿瘤组织、癌旁组织、正常黏膜组织中Bmi-1蛋白的表达情况;评价基因的表达与临床病理及分期的关系。结果大肠癌组织Bmi-1蛋白的阳性表达率显著高于瘤旁及正常组织(P<0.05);Bmi-1 mRNA的阳性表达在肿瘤与正常(P=0.086)、肿瘤与瘤旁间(P=0.385)无明显差异。在大肠癌中合并淋巴结转移者Bmi-1 mRNA及Bmi-1蛋白表达水平显著高于未转移者(P<0.05);Duke分期C和D期患者Bmi-1 mRNA表达水平明显升高(P<0.05),癌组织浸润深度越深Bmi-1 mRNA及Bmi-1蛋白表达水平越高。肿瘤分化程度越低Bmi-1蛋白表达强度越强。结论 Bmi-1与大肠癌的发生发展密切相关,检测其表达水平对评估大肠癌患者预后及指导今后治疗有一定意义。 Objective To investigate the expressions of Bmi-1 in colorectal cancer and its correlation with clinical pathological characteristics.Methods The expressions of Bmi-1 mRNA in 35 cases of colorectal cancer,adjacent and distal non-cancerous tissues were quantified by SYBR Green real-time RT-PCR.The expression of Bmi-1 protein and relationship with clinical parameters and the differential expression of genes were detected by HE staining and immunohistochemistry (SP method).Results There was no statistically significant difference among cancer tissues,adjacent and distal non-cancerous tissues,and normal tissues for positive expression of Bmi-1 mRNA(P 0.05).The protein expression was significantly higher in cancer tissues than that in normal tissues (P 0.05).The expression of tissue Bmi-1 mRNA in colorectal cancer patients with lymph-node metastasis was significantly higher than those without metastasis.While in patients with deeper infiltration and Dukes'C and D,the expression of Bmi-1 increased significantly.Conclusions Bmi-1 expressions in colorectal cancer are closely related to the infiltration and metastasis of colorectal cancer,which is helpful to evaluate the prognosis and guide the future treatment of patients with colorectal cancer.
出处 《现代消化及介入诊疗》 2011年第1期1-5,共5页 Modern Interventional Diagnosis and Treatment in Gastroenterology
基金 广东省自然科学基金(9151008004000014)
关键词 大肠癌 BMI-1 基因 Colorectal Neoplasms Bmi-1 Gene
  • 相关文献

参考文献15

  • 1Alkema MJ, Bronk M, Verhoeven E, et al. Identification of Bmilinteracting proteins as constituents of a multimeric mammalian polycomb complex. Genes Dev, 1997,11:226-240.
  • 2Jacobs JJ, Scheijien B, Voncken JW, et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev, 1999,13:2678-2690.
  • 3Park IK, Morrison SJ, Clarke MF. Bmil, stem cells, and senescence regulation. J Clin Invest, 2004,113:175-179.
  • 4Wang H, Pan K, Zhang HK, et al. Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol, 2008,134:535-541.
  • 5Cui H, Hu B, Li T, et al. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol, 2007,170:1370-1378.
  • 6Kang MK, Kim RH, Kim S J, et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer, 2007,96:126-133.
  • 7Tateishi K, Ohta M, Kanai F, et al. Dysregulated expression of stem cell factor Bmil in precancerous lesions of the gastrointestinal tract. Clin Cancer Res, 2006,12:6960-6966.
  • 8Kim JH, Yoon SY, Jeong SH, et al. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast, 2004,13:383-388.
  • 9Mihara K, Chowdhury M, Nakaju N, et al. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. Blood, 2006,107:305-308.
  • 10Song LB, Zeng MS, Liao WT, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res, 2006, 66:6225-6232.

同被引文献55

  • 1Vonlanthen S,Heighway J,Altermatt H J,et al.The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.Br J Cancer,2001,84:1372-1376.
  • 2Honig A,Weidler C,H?usler S,et al.Overexpression of polycomb protein BMI-1 in human specimens of breast,ovarian,endometrial and cervical cancer.Anticancer Res,2010,30:1559-1564.
  • 3Liu WL,Guo XZ,Zhang LJ,et al.Prognostic relevance of Bmi-1expression and autoantibodies in esophageal squamous cell carcinoma.BMC Cancer,2010,10:467.
  • 4Li DW,Tang HM,Fan JW,et al.Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer.J Cancer Res Clin Oncol,2010,136:997-1006.
  • 5Tsukuma H,Ajiki W.Descriptive epidemiology of colorectal cancer--international comparison.Nihon Rinsho,2003,61 (Suppl 7):25-30.
  • 6Haupt Y,Alexander WS,Barri G,et al.Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice.Cell,1991,65:753-763.
  • 7Kim JH,Yoon SY,Kim CN,et al.The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins.Cancer Lett,2004,203:217-224.
  • 8Xiao J,Deng C.Knockdown of Bmi-1 impairs growth and invasiveness of human gastric carcinoma cells.Oncol Res,2009,17:613-620.
  • 9Zhu W,Huang L,Xu X,et al.Anti-proliferation effect of BMI-1 in U937 cells with siRNA.Int J Mol Med,2010,25:889-895.
  • 10Xu Z,Liu H,Lv X,et al.Knockdown of the Bmi-1 oncogene inhibits cell proliferation and induces cell apoptosis and is involved in the decrease of Akt phosphorylation in the human breast carcinoma cell line MCF-7.Oncol Rep,2011,25:409-418.

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部